These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 7711410)

  • 41. Treatment of fourteen chronic active HBsAg+, HBeAg+ hepatitis patients with low dose natural human interferon alpha administered orally.
    Zielińska W; Paszkiewicz J; Korczak A; Własiuk M; Zółtowska A; Szutowicz A; Cummins JM; Georgiades JA
    Arch Immunol Ther Exp (Warsz); 1993; 41(3-4):241-51. PubMed ID: 8129568
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment of chronic hepatitis B (HBeAg-HBV DNA-positive) with lymphoblastoid alpha interferon with or without corticosteroids: short- and long-term follow-up.
    Zavaglia C; Bottelli R; Bellati G; Asti L; Mondazzi L; Iamoni G; Zanetti A; Tanzi E; Fesce E; Gelosa F; Maggi G; Ideo G
    Ital J Gastroenterol; 1996; 28(6):324-31. PubMed ID: 8891847
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Randomised controlled trial of recombinant human interferon -alpha A for chronic active hepatitis B.
    Williams SJ; Craig PI; Cooksley WG; Bye WA; Bilous M; Grierson JM; Nightingale BN; Burnett L; Hensley WJ; Batey RG
    Aust N Z J Med; 1990 Feb; 20(1):9-19. PubMed ID: 2181991
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Long term study of the treatment with recombinant alfa 2b interferon in chronic active hepatitis due to B virus in children and adolescents].
    Castañeda Guillot C; Escobar Capote MD; García Bacallao E; Borbolla Bousquets E
    G E N; 1994; 48(4):219-25. PubMed ID: 7557276
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical evaluation and applications of the Amplicor HBV Monitor test, a quantitative HBV DNA PCR assay.
    Gerken G; Gomes J; Lampertico P; Colombo M; Rothaar T; Trippler M; Colucci G
    J Virol Methods; 1998 Oct; 74(2):155-65. PubMed ID: 9779615
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Measurement of HBsAg to monitor hepatitis B viral replication in patients on alpha-interferon therapy.
    Janssen HL; Kerhof-Los CJ; Heijtink RA; Schalm SW
    Antiviral Res; 1994 Apr; 23(3-4):251-7. PubMed ID: 8042863
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group.
    Perrillo RP; Schiff ER; Davis GL; Bodenheimer HC; Lindsay K; Payne J; Dienstag JL; O'Brien C; Tamburro C; Jacobson IM; Sampliner R; Feit D; Lefkowitch J; Kuhns M; Meschievitz C; Sanghvi B; Albrecht J; Gibas A;
    N Engl J Med; 1990 Aug; 323(5):295-301. PubMed ID: 2195346
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of chronic hepatitis B with interferon alfa-2b.
    Müller R; Baumgarten R; Markus R; Schulz M; Wittenberg H; Hintsche-Kilger B; Fengler JD; Von Wussow P; Meisel H; Klein H
    J Hepatol; 1990; 11 Suppl 1():S137-40. PubMed ID: 2079572
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of HBeAg positive chronic hepatitis B: interferon or nucleoside analogues.
    Dusheiko G
    Liver Int; 2013 Feb; 33 Suppl 1():137-50. PubMed ID: 23286858
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pilot study of combination therapy with ribavirin and interferon alfa for the retreatment of chronic hepatitis B e antibody-positive patients.
    Cotonat T; Quiroga JA; López-Alcorocho JM; Clouet R; Pardo M; Manzarbeitia F; Carreño V
    Hepatology; 2000 Feb; 31(2):502-6. PubMed ID: 10655277
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Glomerulonephritis caused by chronic hepatitis B virus infection: treatment with recombinant human alpha-interferon.
    Lisker-Melman M; Webb D; Di Bisceglie AM; Kassianides C; Martin P; Rustgi V; Waggoner JG; Park Y; Hoofnagle JH
    Ann Intern Med; 1989 Sep; 111(6):479-83. PubMed ID: 2774373
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interferon alpha-2b treatment in an HIV-infected patient with hepatitis B virus induced nephrotic syndrome.
    Lidman C; Magnius L; Norder H; Weiland O
    Scand J Infect Dis; 1993; 25(1):133-5. PubMed ID: 8460337
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-term remission of chronic hepatitis B after alpha-interferon therapy.
    Korenman J; Baker B; Waggoner J; Everhart JE; Di Bisceglie AM; Hoofnagle JH
    Ann Intern Med; 1991 Apr; 114(8):629-34. PubMed ID: 2003708
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of long-term lamivudine in chronic hepatitis B virus-infected children.
    Ozgenç F; Arikan C; Sertoz RY; Nart D; Aydogdu S; Yagci RV
    Antivir Ther; 2004 Oct; 9(5):729-32. PubMed ID: 15535410
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of recombinant alpha 2 interferon with or without prednisone in Chinese HBsAg carrier children.
    Lai CL; Lin HJ; Lau JN; Flok AS; Wu PC; Chung HT; Wong LK; Leung MP; Yeung CY
    Q J Med; 1991 Feb; 78(286):155-63. PubMed ID: 2031078
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of chronic hepatitis B in children with prednisone followed by alfa-interferon: a controlled randomized study.
    Utili R; Sagnelli E; Gaeta GB; Galanti B; Nardiello S; Felaco FM; Pasquale G; Marrone A; Aprea L; Pizzella T
    J Hepatol; 1994 Feb; 20(2):163-7. PubMed ID: 8006395
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B.
    Niederau C; Heintges T; Lange S; Goldmann G; Niederau CM; Mohr L; Häussinger D
    N Engl J Med; 1996 May; 334(22):1422-7. PubMed ID: 8618580
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of switching from treatment with nucleos(t)ide analogs to pegylated interferon α-2a on virological and serological responses in chronic hepatitis B patients.
    He LT; Ye XG; Zhou XY
    World J Gastroenterol; 2016 Dec; 22(46):10210-10218. PubMed ID: 28028369
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Models for predicting hepatitis B e antigen seroconversion in response to interferon-α in chronic hepatitis B patients.
    Wang CT; Zhang YF; Sun BH; Dai Y; Zhu HL; Xu YH; Lu MJ; Yang DL; Li X; Zhang ZH
    World J Gastroenterol; 2015 May; 21(18):5668-76. PubMed ID: 25987794
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of interferon in the treatment of chronic viral hepatitis.
    Gibas AL
    Gastroenterologist; 1993 Jun; 1(2):129-42. PubMed ID: 8049886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.